INNOVATE Corp
For the period ended Sep 30, 2024. Filed Nov 6, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 6, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
(3) Revenue and Contracts in Process
- Revenue and Contracts in Process
Revenue from contracts with customers consisted of the following (in millions):
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Infrastructure | $232.8 | $369.3 | $845.9 | $1,043.4 |
| Life Sciences | 3.0 | 0.6 | 5.7 | 1.8 |
| Spectrum | 6.4 | 5.4 | 18.9 | 16.8 |
| Total revenue | $242.2 | $375.3 | $870.5 | $1,062.0 |
Accounts receivables, net, from contracts with customers consisted of the following (in millions):
| September 30,2024 | December 31,2023 | |
|---|---|---|
| Infrastructure | $182.3 | $271.5 |
| Life Sciences | 0.5 | 0.3 |
| Spectrum | 1.7 | 1.4 |
| Total accounts receivables with customers | $184.5 | $273.2 |
As of January 1, 2023, accounts receivable, net, from contracts with customers totaled $250.4 million.
The following table disaggregates DBMG's revenue by market (in millions):
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Industrial | $64.7 | $115.9 | $242.5 | $322.7 |
| Commercial | 57.1 | 100.6 | 230.9 | 311.4 |
| Transportation | 58.2 | 75.5 | 228.0 | 176.7 |
| Healthcare | 40.9 | 38.3 | 114.4 | 114.4 |
| Convention | 1.8 | 35.5 | 10.3 | 97.0 |
| Government | 3.9 | 1.6 | 5.6 | 8.2 |
| Energy | 1.9 | 1.0 | 5.7 | 7.0 |
| Leisure | 4.3 | 0.9 | 6.9 | 5.5 |
| Total revenue from contracts with customers | $232.8 | $369.3 | $844.3 | $1,042.9 |
| Other revenue | — | — | 1.6 | 0.5 |
| Total Infrastructure segment revenue | $232.8 | $369.3 | $845.9 | $1,043.4 |
Contract assets and contract liabilities consisted of the following (in millions):
| September 30,2024 | December 31, 2023 | |
|---|---|---|
| Costs incurred on contracts in progress | $2,725.7 | $2,811.8 |
| Estimated earnings | 471.8 | 510.1 |
| Contract revenue earned on uncompleted contracts | 3,197.5 | 3,321.9 |
| Less: progress billings | 3,169.2 | 3,356.8 |
| $28.3 | $(34.9) | |
| The above is included in the accompanying Condensed Consolidated Balance Sheets under the following line items: | ||
| Contract assets | $113.8 | $118.6 |
| Contract liabilities | (85.5) | (153.5) |
| $28.3 | $(34.9) | |
| September 30,2024 | December 31,2023 | |
|---|---|---|
| Cost in excess of billings and estimated earnings | $50.1 | $73.8 |
| Conditional retainage | 63.7 | 44.8 |
| Contract assets | $113.8 | $118.6 |
| Billings in excess of costs and estimated earnings | $(125.8) | $(229.3) |
| Conditional retainage | 40.3 | 75.8 |
| Contract liabilities | $(85.5) | $(153.5) |
As of January 1, 2023, contract assets were $165.1 million and contract liabilities were $98.6 million.
Contract assets and liabilities fluctuate period to period based on various factors, including, among others, changes in the number and size of projects in progress at period end; variability in billing and payment terms, such as up-front or advance billings, interim or milestone billings, or deferred billings; and recognized unapproved change orders, contract claims and changes in estimated costs to complete in the normal course of business.
The change in contract assets during the nine months ended September 30, 2024, is a result of the recording of $63.6 million of contract assets driven by new commercial projects, offset by $68.4 million of contract assets transferred to receivables from contract assets recognized at the beginning of the period, including from certain large projects at or nearing completion and the corresponding billing of amounts previously recorded as contract assets.
The change in contract liabilities during the nine months ended September 30, 2024, is a result of the recording of periodic contract liabilities of $78.3 million driven largely by new commercial projects, offset by revenue recognized that was included in the contract liability balance at the beginning of the period in the amount of $146.3 million, including from certain large projects at or nearing completion.
Transaction Price Allocated to Remaining Unsatisfied Performance Obligations
As of September 30, 2024, the transaction price allocated to remaining unsatisfied performance obligations consisted of the following (in millions):
| Within One Year | Within Five Years | Total | |
|---|---|---|---|
| Healthcare | $211.3 | $105.3 | $316.6 |
| Commercial | 204.6 | 4.4 | 209.0 |
| Industrial | 111.7 | 7.5 | 119.2 |
| Transportation | 134.0 | 75.3 | 209.3 |
| Leisure | 21.0 | 1.1 | 22.1 |
| Government | 14.7 | — | 14.7 |
| Convention | 11.0 | — | 11.0 |
| Energy | 2.1 | — | 2.1 |
| Remaining unsatisfied performance obligations | $710.4 | $193.6 | $904.0 |
DBMG's remaining unsatisfied performance obligations increase with awards of new contracts and decrease as it performs work and recognizes revenue on existing contracts. DBMG includes a project within its remaining unsatisfied performance obligations at such time the project is awarded and agreement on contract terms has been reached. DBMG's remaining unsatisfied performance obligations include amounts related to contracts for which a fixed price contract value is not assigned when a reasonable estimate of total transaction price can be made. DBMG expects to recognize this revenue approximately within the next 2.5 years.
Remaining unsatisfied performance obligations include unrecognized revenues to be realized from uncompleted construction contracts. Although many of DBMG's contracts are subject to cancellation at the election of its customers, in accordance with industry practice, DBMG does not limit the amount of unrecognized revenue included within its remaining unsatisfied performance obligations due to the inherent substantial economic penalty that would be incurred by its customers upon cancellation.
Life Sciences Segment
The following table disaggregates the Life Sciences segment's revenue by type (in millions):
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Systems and consumables revenue | $3.0 | $0.6 | $5.7 | $1.8 |
| Total Life Sciences segment revenue | $3.0 | $0.6 | $5.7 | $1.8 |
Spectrum Segment
The following table disaggregates the Spectrum segment's revenue by type (in millions):
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Broadcast station | $6.4 | $5.4 | $18.9 | $16.2 |
| Other | — | — | — | 0.6 |
| Total Spectrum segment revenue | $6.4 | $5.4 | $18.9 | $16.8 |
Transaction Price Allocated to Remaining Unsatisfied Performance Obligations
As of September 30, 2024, the transaction price allocated to remaining unsatisfied performance obligations consisted of $18.0 million of broadcast station revenues of which $9.6 million is expected to be recognized withinone year and $8.4 million is expected to be recognized within the next 3 years.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.